Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$37.53 - $44.22 $457,866 - $539,484
-12,200 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$37.46 - $42.44 $457,012 - $517,768
12,200 New
12,200 $12,000
Q4 2021

Feb 14, 2022

SELL
$35.17 - $42.48 $696,366 - $841,103
-19,800 Closed
0 $0
Q3 2021

Nov 10, 2021

BUY
$36.14 - $42.24 $715,572 - $836,352
19,800 New
19,800 $5,000

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $10.6B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.